#IDMastodon #Viralimmmunology Clinical characteristics of #covid19vaccine in cancer patients with #Immunecheckpointinhibitors & Interaction between ICIs - #SarsCoV2 infection-#COVID19vaccines . Cancer patients are thought at high risk for #COVID19. It seems prudent to comprehensively assess risk factors & symptoms of #SARSCoV2 infection in all patients who have received or are receiving ICI therapy & to screen for #COVID PCR early for a definitive diagnosis, especially for lung cancer patients.

🎄Recap @Nature #Clinicaloncology #Clinicalreviews current evidence for chronic immune toxicities #COVID19 & the long-term implications of these effects for patients receiving #Immunecheckpointinhibitors
📌https://www.nature.com/articles/s41571-022-00600-w
📌 https://www.nature.com/articles/s41591-021-01643-9
📌 https://www.nature.com/articles/s41590-022-01291-2
📌 https://jhoonline.biomedcentral.com/articles/10.1186/s13045-022-01325-0
📌 https://www.sciencedirect.com/science/article/abs/pii/S001430572200475X
📌 https://www.nature.com/articles/s43018-022-00418-6
📌https://www.nature.com/articles/s41571-019-0218-0
📌 https://www.nature.com/articles/s41568-022-00491-0
📌https://www.nature.com/articles/s41573-021-00259-5
📌https://www.nature.com/articles/s41571-022-00600-w